Informations:
Erreur:
ID
14286
Description
Responsiveness of Lower Airways in Adult Patients (18-60 Years) With Stable Asthma After Treatment With Ciclesonide and Fluticasone Propionate (BY9010/NL-101); ODM derived from: https://clinicaltrials.gov/show/NCT00306163
Lien
https://clinicaltrials.gov/show/NCT00306163
Mots-clés
Versions (1)
- 07/04/2016 07/04/2016 -
Détendeur de droits
CC BY-NC 3.0
Téléchargé le
7 avril 2016
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY-NC 3.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Asthma NCT00306163
Eligibility Asthma NCT00306163
- StudyEvent: Eligibility
Similar models
Eligibility Asthma NCT00306163
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
history of bronchial asthma
Item
history of bronchial asthma
boolean
C0004096 (UMLS CUI [1])
fev1
Item
fev1 > 1.20 l
boolean
C0748133 (UMLS CUI [1])
positive skin prick test
Item
positive skin prick test
boolean
C0430561 (UMLS CUI [1])
fluticasone propionate
Item
not more than 500 mcg/day fluticasone propionate or equivalent for at least 28 days prior to baseline visit
boolean
C0117996 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,2])
exclusion criteria
Item
main exclusion criteria:
boolean
C0680251 (UMLS CUI [1])
clinically relevant abnormal laboratory values
Item
clinically relevant abnormal laboratory values
boolean
C1254595 (UMLS CUI [1,1])
C2826293 (UMLS CUI [1,2])
C2826293 (UMLS CUI [1,2])
concomitant severe diseases, diseases expected to interfere with the outcome of the study and diseases which are contra-indications for the use of inhaled steroids
Item
concomitant severe diseases, diseases expected to interfere with the outcome of the study and diseases which are contra-indications for the use of inhaled steroids
boolean
C1321605 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
C0586793 (UMLS CUI [2,1])
C0439801 (UMLS CUI [2,2])
C0009488 (UMLS CUI [2,3])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
C0586793 (UMLS CUI [2,1])
C0439801 (UMLS CUI [2,2])
C0009488 (UMLS CUI [2,3])
copd or other relevant lung diseases
Item
chronic obstructive pulmonary disease (copd) and /or other relevant lung diseases
boolean
C0024117 (UMLS CUI [1,1])
C0024115 (UMLS CUI [1,2])
C0024115 (UMLS CUI [1,2])
asthma exacerbation
Item
one asthma exacerbation within 2 months or more than 3 exacerbations within the last year prior to baseline visit
boolean
C0349790 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,2])
smoking history
Item
current smokers or ex-smokers with more than 10 pack years, or having smoked within 1 year prior to baseline visit
boolean
C1519384 (UMLS CUI [1])
C1277691 (UMLS CUI [2])
C1277691 (UMLS CUI [2])
saline challenge
Item
positive response to saline challenge at baseline visits
boolean
bronchial hyperresponsiveness
Item
positive bronchial hyperresponsiveness
boolean
C0085129 (UMLS CUI [1])